Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing

Plus news about Breye, Immix and Aptadir. Ascletis takes on injectables with psoriasis pill: The Hong Kong-listed biotech is developing a small-molecule IL-17A inhibitor, going after the same target as injectables ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 29 September →